Fennec Pharmaceuticals (FENC) Enterprise Value (2010 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Enterprise Value came in at -$36.8 million in Q4 2025, down 38.12% YoY from -$59.5 million in Q4 2024, and down 67.62% on a QoQ basis from -$21.9 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Enterprise Value (2010 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 16 years of Enterprise Value data on file, last reported at -$36.8 million in Q4 2025.
- Quarterly Enterprise Value fell 38.12% year-over-year to -$36.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$36.8 million (down 38.12% YoY) and the FY2025 annual result came in at -$36.8 million, down 38.12% from the prior year.
- Enterprise Value eased to -$36.8 million in Q4 2025, from -$21.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$12.4 million in Q3 2023 to a low of -$51.2 million in Q1 2024.
- A 5-year average of -$25.1 million and a median of -$23.2 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value jumped 58.33% — and 2024, when it plunged 285.74%.
- Tracing FENC's Enterprise Value over 5 years: stood at -$21.1 million in 2021, then declined by 12.67% to -$23.8 million in 2022, then jumped by 44.19% to -$13.3 million in 2023, then slumped by 100.72% to -$26.6 million in 2024, then tumbled by 38.12% to -$36.8 million in 2025.
- The last three Enterprise Value figures came in at -$36.8 million (Q4 2025), -$21.9 million (Q3 2025), and -$18.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn | -41.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -41.25 Mn |
| Dec 31, 2025 | -36.79 Mn |
| Sep 30, 2025 | -21.95 Mn |
| Jun 30, 2025 | -18.71 Mn |
| Mar 31, 2025 | -22.68 Mn |
| Dec 31, 2024 | -26.63 Mn |
| Sep 30, 2024 | -40.32 Mn |
| Jun 30, 2024 | -43.05 Mn |
| Mar 31, 2024 | -51.18 Mn |
| Dec 31, 2023 | -13.27 Mn |
| Sep 30, 2023 | -12.40 Mn |
| Jun 30, 2023 | -14.96 Mn |
| Mar 31, 2023 | -13.27 Mn |
| Dec 31, 2022 | -23.77 Mn |
| Sep 30, 2022 | -29.75 Mn |
| Jun 30, 2022 | -14.92 Mn |
| Mar 31, 2022 | -18.26 Mn |
| Dec 31, 2021 | -21.10 Mn |
| Sep 30, 2021 | -24.34 Mn |
| Jun 30, 2021 | -27.29 Mn |